Skip to main content
. 2022 Mar 22;13(4):8000–8012. doi: 10.1080/21655979.2022.2048991

Figure 1.

Figure 1.

Higher UBE2B expression was linked to a poorer prognosis of ovarian cancer. (a) The expression of UBE2B in the normal fallopian tube (GTEx-FT, n = 5) and ovary tissues (n = 88) (GTEx-OV) and ovarian cancer tissues in TCGA-OV (n = 418). (b,c) K-M survival curves were generated to detect the difference in PFS (b) and DSS (c) between patients with high and low UBE2B expression, using the best cutoff value (Youden Index) identified in ROC analysis.